2026 First Half Results

Unilever posts modest growth, strong cash returns, and incremental margin gains in H1 2026.

What the company is saying

Unilever frames its first half 2026 results as evidence of strong, volume-led growth, highlighting a 4.8% underlying sales increase driven by 4.2% volume and 0.6% price. The company emphasizes its 'Power Brands' as the main growth engine, citing 6.0% USG and 5.4% volume growth for this segment, which makes up 78% of turnover. Operational achievements are foregrounded, including the early completion of an €800 million productivity programme and a €1.5 billion share buyback. The narrative stresses resilience against currency headwinds and positions the Foods business separation as a value unlock, though without quantifying this. Management projects full-year USG of 4–6% and a modest margin improvement, using confident but measured language. The announcement is data-heavy, but some claims—such as the impact of operational performance versus currency and the competitive nature of marketing spend—are asserted without supporting breakdowns.

What the data suggests

Headline numbers show turnover up 0.5% to €25.6 billion, with underlying sales growth of 4.8% primarily from volume gains. Underlying operating profit rose 0.9% to €5.2 billion, and the operating margin improved by 10bps to 20.3%. Gross margin was 46.8%, and brand and marketing investment accounted for 16.1% of turnover. Underlying EPS increased 2.4% to €1.61, but diluted EPS fell 2.5% to €1.38, and net profit declined 3.5% to €3.3 billion, indicating some bottom-line pressure. Free cash flow was €1.5 billion, supporting a 3% dividend increase and the completion of a €1.5 billion share buyback. Segment data shows Personal Care up 4.2%, Home Care up 1.5%, Beauty & Wellbeing up 0.3%, and Foods down 4.0%. The data supports the narrative of operational improvement and cash returns, but lacks detail on the financial impact of recent M&A and the Foods separation.

Analysis

The announcement's tone is positive, but the language is largely proportionate to the disclosed results. Most key claims are realised and supported by concrete financial data, including turnover, operating margin, EPS, and cash flow. Forward-looking statements (such as full-year sales growth and margin guidance, and the Foods separation) are present but do not dominate the narrative. The majority of benefits discussed are either already realised or expected within the next 6-24 months, with no evidence of long-dated, uncertain returns tied to large new capital outlays. Some phrases (e.g., 'unlocking value', 'leading pureplay HPC company') are aspirational but do not materially inflate the overall signal. The absence of detailed breakdowns for certain claims (e.g., impact of operational performance vs. currency) is noted, but profitability and cash flow metrics are disclosed, supporting a weak_positive signal.

Risk flags

• ●The divergence between underlying EPS (+2.4%) and diluted EPS (–2.5%) signals potential non-operational charges or dilution effects not fully explained in the announcement. This matters because it clouds the true earnings power available to shareholders, and the lack of a breakdown leaves the source of the discrepancy unclear.
• ●Net profit declined by 3.5% to €3.3 billion despite operational improvements, suggesting margin pressures or exceptional items that are not detailed. This raises questions about the sustainability of bottom-line growth if cost inflation or restructuring charges persist.
• ●Claims about the Foods separation 'unlocking value' and transforming Unilever into a 'leading pureplay HPC company' are not supported by quantified synergies, cost savings, or pro forma financials. The absence of these details makes it difficult to assess the true financial impact and execution risk of the transaction.
• ●The announcement asserts that operational performance and net acquisitions offset adverse currency, but provides no numerical breakdown of these effects. Without this, investors cannot assess the underlying drivers of growth or the company's exposure to further currency volatility.

Bottom line

Unilever's first half 2026 results show incremental improvement in sales, margin, and cash returns, with operational gains largely realised and further upside tied to the successful separation of the Foods business. The company delivers on its productivity and buyback promises, but the lack of detail on the financial impact of M&A and the Foods transaction limits visibility into future earnings power. Discrepancies between underlying and diluted EPS, as well as a decline in net profit, highlight unresolved bottom-line pressures. The narrative is credible at the headline level but would benefit from more granular disclosures, especially regarding the Foods separation and currency impacts. Investors should focus on the execution of the Foods divestment, the sustainability of volume-led growth, and the reconciliation of EPS metrics. The most important takeaway is that while operational momentum is positive, the full financial implications of portfolio changes remain opaque.

Announcement summary

(LSE/AIM:ULVR) Unilever PLC reported first half 2026 turnover of €25.6 billion, up 0.5% versus the prior year, with underlying sales growth (USG) of 4.8% driven by 4.2% volume and 0.6% price. Underlying operating profit was €5.2 billion, up 0.9%, and underlying operating margin increased to 20.3%, up 10bps. The company completed an €800 million productivity programme ahead of plan and finished a €1.5 billion share buyback in June 2026. Quarterly dividend for Q2 2026 is €0.4664 per share, up 3% versus Q2 2025. Unilever completed several acquisitions and divestments, including the sale of its Home Care businesses in Colombia and Ecuador, and the acquisition of Grüns in June 2026. The company projects full year 2026 underlying sales growth within a 4% to 6% range, with around 3% underlying volume growth and a modest improvement in underlying operating margin versus 20.0% in 2025.

Disagree with this article?